INVO Fertility (IVF) Return on Sales Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | 8.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.00 |
| Jun 30, 2025 | 19.00 |
| Mar 31, 2025 | 6.00 |
| Dec 31, 2024 | -2.00 |
| Sep 30, 2024 | 10.00 |
| Jun 30, 2024 | 7.00 |
| Mar 31, 2024 | 3.00 |
| Dec 31, 2023 | 18.00 |
| Sep 30, 2023 | 4.00 |
| Jun 30, 2023 | -2.00 |
| Mar 31, 2023 | -2.00 |
| Dec 31, 2022 | -8.00 |
| Sep 30, 2022 | -8.00 |
| Jun 30, 2022 | -19.00 |
| Mar 31, 2022 | -14.00 |
| Dec 31, 2021 | 5.00 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | 8.00 |
| Mar 31, 2021 | -2.00 |
| Dec 31, 2020 | -17.00 |
| Sep 30, 2020 | -3.00 |
| Jun 30, 2020 | -4.00 |
| Mar 31, 2020 | -1.00 |
| Dec 31, 2019 | 27.00 |
| Sep 30, 2019 | 9.00 |
| Jun 30, 2019 | 267.00 |
| Mar 31, 2019 | 8.00 |
| Dec 31, 2018 | 419.00 |
| Sep 30, 2018 | 47.00 |
| Jun 30, 2018 | 784.00 |
| Mar 31, 2018 | 39.00 |
| Dec 31, 2017 | 102.00 |
| Sep 30, 2017 | 23.00 |
| Jun 30, 2017 | 85.00 |
| Mar 31, 2017 | 8.00 |
| Dec 31, 2016 | -20.00 |
| Sep 30, 2016 | 709.00 |
| Jun 30, 2016 | -238.00 |
| Mar 31, 2016 | 27.00 |
| Dec 31, 2015 | -423.00 |
| Sep 30, 2015 | 17.00 |
| Jun 30, 2015 | -790.00 |
| Mar 31, 2015 | -18.00 |
| Dec 31, 2014 | -53.00 |
| Sep 30, 2014 | -17.00 |
| Jun 30, 2014 | -72.00 |